company-logoAkili, Inc.$0.43
%
Analyst Rating: Hold

Stock Details

CEO

Matthew Franklin

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Full Time Employees

68

Address

125 Broad Street, Boston, MA, 02110

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Akili, Inc.  $0.43

EPS

Revenue

Institutional Holder

Congress Tracker 

Insider Trading of Key Employees

Financial News: AKLI